Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer, and it is characterized by the absence of Estrogen receptor (ER), Progesterone receptor (PR) and Human epidermal growth factor receptor-2 (HER-2) on the surface of tumor cell membrane. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.